Skip to main content
Premium Trial:

Request an Annual Quote

Sema4: William Oh

Sema4 has appointed William Oh to the position of chief medical science officer, where he will drive strategy, scientific collaborations, clinical development, and adoption of the firm's technology.

Oh comes to Sema4 from Mount Sinai Health System, where he was chief of hematology and medical oncology and the deputy director of the Tisch Cancer Institute at the Icahn School of Medicine. He will continue to see patients at Mount Sinai.

Oh holds an MD from the New York University School of Medicine.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.